<DOC>
	<DOCNO>NCT02120235</DOCNO>
	<brief_summary>Although lysosomal storage disorder , Fabry disease , Gaucher disease , Pompe disease , represent serious challenge healthcare system , study yet investigate prevalence diseases US . Frequently , patient show progressive worsening symptom several year get diagnose . Since many disease manage therapeutically , important identify treat patient order avoid organ damage . The investigator aim undertake screening study identifies undiagnosed patient lysosomal storage disorder determine prevalence disease special focus underrepresented minority group .</brief_summary>
	<brief_title>Investigating Lysosomal Storage Diseases Minority Groups</brief_title>
	<detailed_description />
	<mesh_term>Fabry Disease</mesh_term>
	<mesh_term>Gaucher Disease</mesh_term>
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<mesh_term>Lysosomal Storage Diseases</mesh_term>
	<mesh_term>Pick Disease Brain</mesh_term>
	<mesh_term>Aphasia , Primary Progressive</mesh_term>
	<mesh_term>Frontotemporal Dementia</mesh_term>
	<mesh_term>Niemann-Pick Diseases</mesh_term>
	<mesh_term>Niemann-Pick Disease , Type A</mesh_term>
	<mesh_term>Niemann-Pick Disease , Type C</mesh_term>
	<criteria>Subject great equal 1 day age less equal 100 year age Subject manage physician Washington , D.C metro area Subject get blood work part standard clinical care least 60 uL blood remain tube clinical test run Absolute contraindication blood draw Subject trace back refer physician upon positive screening result</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Lysosomal storage disorder</keyword>
	<keyword>LSD</keyword>
	<keyword>Gaucher disease</keyword>
	<keyword>Fabry disease</keyword>
	<keyword>Pompe disease</keyword>
	<keyword>Niemann-Pick disease</keyword>
</DOC>